March 12, 2026
TOPLINE: In adults and adolescents with allergic rhinoconjunctivitis (ARC), sublingual immunotherapy (SLIT) with standardized extracts of house dust mite allergens reduced symptoms and medication use, improved […]
March 11, 2026
PHILADELPHIA — Individuals with preexisting cardiovascular disease (CVD) who are admitted to the emergency department for an anaphylactic reaction have significantly poorer outcomes, including a higher […]
March 10, 2026
TOPLINE: Dupilumab yielded sustained reductions in nasal polyp burden and improvements in smell function and quality of life (QOL) in patients with chronic rhinosinusitis with nasal […]
March 10, 2026
Children who develop eczema or other skin and respiratory allergies early in life face a higher risk of developing a food allergy, according to a recent […]
March 9, 2026
TOPLINE: A few exhaled volatile organic compounds — specifically decane and nonadecane — showed potential to identify allergic patients among those with chronic rhinitis, with 76.5% […]
March 5, 2026
PHILADELPHIA — The investigational drug navenibart reduced attacks of hereditary angioedema by an average 91% over 1 year with only twice-yearly dosing and no serious adverse […]
March 5, 2026
Chronic rhinosinusitis may be linked to an increased risk for cancer, according to a study of patients in Asia. The study found that chronic rhinosinusitis was […]
March 4, 2026
TOPLINE: A 5-day amoxicillin challenge was feasible for evaluating delayed penicillin allergy, with more than 80% of participants completing the protocol; immune‑mediated reactions were uncommon but […]
March 3, 2026
Food allergy affects more than 33 million people in the United States — about 1 in 10 adults and 1 in 13 children — and the […]